Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia
Abstract Objective: Emerging blood‐based screening technologies for bowel cancer may improve screening participation compared to at‐home stool sampling. This study assessed the impact of different screening delivery scenarios with increasing health system interactions on sampling preferences and lik...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-08-01
|
| Series: | Australian and New Zealand Journal of Public Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1753-6405.12523 |
| _version_ | 1797708648171962368 |
|---|---|
| author | Ian T. Zajac Amy Duncan Deborah Turnbull Carlene Wilson Ingrid Flight |
| author_facet | Ian T. Zajac Amy Duncan Deborah Turnbull Carlene Wilson Ingrid Flight |
| author_sort | Ian T. Zajac |
| collection | DOAJ |
| description | Abstract Objective: Emerging blood‐based screening technologies for bowel cancer may improve screening participation compared to at‐home stool sampling. This study assessed the impact of different screening delivery scenarios with increasing health system interactions on sampling preferences and likelihood of screening participation. Methods: N=1,561 persons aged 45 to 74 years completed a behavioural survey measuring demographics, readiness to screen, overall collection method preference, and proposed participation in stool and blood methods across four screening scenarios differing in terms of the number of required health system interactions. Results: Overall, respondents preferred a blood test (79.6%) compared to a stool test (20.4%). However, increasing health system interactions had a strong impact on the likelihood of participating in either sampling method (p<0.001). Moreover, likelihood of participating in each of the four blood‐screening scenarios was significantly lower than the current at‐home stool sampling approach (all p<0.001). Conclusions: Blood‐based screening methods require increased contact with the health system but these interactions have negative impact on screening likelihood. All blood‐based scenarios showed lower screening likelihood ratings than the current at‐home FIT approach. Thus, blood‐based screening may not resolve suboptimal screening participation rates in Australia. |
| first_indexed | 2024-03-12T06:25:32Z |
| format | Article |
| id | doaj.art-08607ca605f542c785aa5417bfca3981 |
| institution | Directory Open Access Journal |
| issn | 1326-0200 1753-6405 |
| language | English |
| last_indexed | 2024-03-12T06:25:32Z |
| publishDate | 2016-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Australian and New Zealand Journal of Public Health |
| spelling | doaj.art-08607ca605f542c785aa5417bfca39812023-09-03T01:54:42ZengElsevierAustralian and New Zealand Journal of Public Health1326-02001753-64052016-08-0140433734110.1111/1753-6405.12523Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in AustraliaIan T. Zajac0Amy Duncan1Deborah Turnbull2Carlene Wilson3Ingrid Flight4Nutrition and Health Research Program Commonwealth Scientific & Industrial Research Organisation South AustraliaSchool of Psychology University of Adelaide South AustraliaSchool of Psychology University of Adelaide South AustraliaFlinders Centre for Innovation in Cancer Flinders University South AustraliaFlinders Centre for Innovation in Cancer Flinders University South AustraliaAbstract Objective: Emerging blood‐based screening technologies for bowel cancer may improve screening participation compared to at‐home stool sampling. This study assessed the impact of different screening delivery scenarios with increasing health system interactions on sampling preferences and likelihood of screening participation. Methods: N=1,561 persons aged 45 to 74 years completed a behavioural survey measuring demographics, readiness to screen, overall collection method preference, and proposed participation in stool and blood methods across four screening scenarios differing in terms of the number of required health system interactions. Results: Overall, respondents preferred a blood test (79.6%) compared to a stool test (20.4%). However, increasing health system interactions had a strong impact on the likelihood of participating in either sampling method (p<0.001). Moreover, likelihood of participating in each of the four blood‐screening scenarios was significantly lower than the current at‐home stool sampling approach (all p<0.001). Conclusions: Blood‐based screening methods require increased contact with the health system but these interactions have negative impact on screening likelihood. All blood‐based scenarios showed lower screening likelihood ratings than the current at‐home FIT approach. Thus, blood‐based screening may not resolve suboptimal screening participation rates in Australia.https://doi.org/10.1111/1753-6405.12523colorectal cancer screeningfaecal occult blood testscreening participationscreening technologies |
| spellingShingle | Ian T. Zajac Amy Duncan Deborah Turnbull Carlene Wilson Ingrid Flight Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia Australian and New Zealand Journal of Public Health colorectal cancer screening faecal occult blood test screening participation screening technologies |
| title | Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia |
| title_full | Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia |
| title_fullStr | Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia |
| title_full_unstemmed | Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia |
| title_short | Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia |
| title_sort | blood based screening for bowel cancer may not resolve suboptimal screening participation in australia |
| topic | colorectal cancer screening faecal occult blood test screening participation screening technologies |
| url | https://doi.org/10.1111/1753-6405.12523 |
| work_keys_str_mv | AT iantzajac bloodbasedscreeningforbowelcancermaynotresolvesuboptimalscreeningparticipationinaustralia AT amyduncan bloodbasedscreeningforbowelcancermaynotresolvesuboptimalscreeningparticipationinaustralia AT deborahturnbull bloodbasedscreeningforbowelcancermaynotresolvesuboptimalscreeningparticipationinaustralia AT carlenewilson bloodbasedscreeningforbowelcancermaynotresolvesuboptimalscreeningparticipationinaustralia AT ingridflight bloodbasedscreeningforbowelcancermaynotresolvesuboptimalscreeningparticipationinaustralia |